Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RenovoRx (RNXT) Common Equity (2024 - 2025)

Historic Common Equity for RenovoRx (RNXT) over the last 2 years, with Q3 2025 value amounting to $8.1 million.

  • RenovoRx's Common Equity rose 1424.13% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year increase of 1424.13%. This contributed to the annual value of $4.5 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, RenovoRx's Common Equity stood at $8.1 million, which was up 1424.13% from $10.6 million recorded in Q2 2025.
  • Over the past 5 years, RenovoRx's Common Equity peaked at $13.2 million during Q1 2025, and registered a low of $1.8 million during Q1 2024.